Dow Up 0.06% Nasdaq Up 0.16%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
89.83 Up 0.91(1.02%) 11:55AM EDT - Nasdaq Real Time Price
Prev Close:88.92
Open:89.00
Bid:89.79 x 200
Ask:89.99 x 100
1y Target Est:106.33
Beta:2.11
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:87.05 - 90.58
52wk Range:47.03 - 112.57
Volume:227,972
Avg Vol (3m):689,617
Market Cap:6.86B
P/E (ttm):N/A
EPS (ttm):-5.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYUp 1.02%6.86B
MRKUp 1.12%160.82B
PFEUp 0.62%180.43B
VRXUp 0.40%43.83B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):191.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-5.40
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback